hotspot -WSS

hotspot

author：fashion 2025-09-05 11:24:23 - browse：27

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Copay coupons to count toward deductibles, after Biden court move

WSS

Mississippi candidates for statewide offices square off in party primaries

In medicine, common shorthands can shortchange care

Parkinson’s finding may lead to tests and, someday, treatments

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Biden will tout long

My yearlong odyssey to get my son’s ADHD medication covered

knowledge

hotspot

explore

Supreme Court strikes down use of affirmative action

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Affirmative action in medical school literally saved lives

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Bright Health sells Medicare Advantage business to Molina

Prior authorization will have to move faster under new Biden rule

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

In medicine, common shorthands can shortchange care

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

hotspot

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

EU regulator recommends expanding Mounjaro approval to obesity

EU regulator recommends expanding Mounjaro approval to obesity

eGenesis tests gene

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

eGenesis tests gene

focus

hotspot

explore

Wikipedia